The underlying molecular mechanism of apolipoprotein E polymorphism - Relationships to lipid disorders, cardiovascular disease, and Alzheimer's disease

被引：37

作者：

Contois, JH ^{[1
]}

Anamani, DE ^{[1
]}

Tsongalis, GJ ^{[1
]}

机构：

[1] HARTFORD HOSP, DEPT PATHOL & LAB MED, HARTFORD, CT 06102 USA

来源：

CLINICS IN LABORATORY MEDICINE | 1996年 / 16卷 / 01期

关键词：

D O I：

10.1016/S0272-2712(18)30290-7

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

Apolipoprotein E (apo E) polymorphism has important clinical correlates, including disorders of Lipoprotein metabolism and atherosclerosis. This article provides a detailed methodology for apo E genotyping and discusses the link between apo E genotype and type III hyperlipoproteinemia, coronary heart disease (CHD), stroke, and Alzheimer's disease (AD). Although apo E genotype appears to provide significant information concerning the genetic component of CHD and AD risk, more research is needed before genotyping can be recommended as a routine screening tool. The data so far, however, implicate apo E as a major component of the genetic basis of cardiovascular disease and AD.

引用

页码：105 / +

页数：1

共 109 条

[51] APOLIPOPROTEIN-E - CHOLESTEROL TRANSPORT PROTEIN WITH EXPANDING ROLE IN CELL BIOLOGY
MAHLEY, RW
[J]. SCIENCE, 1988, 240 (4852) : 622 - 630
[52] APOLIPOPROTEIN-E POLYMORPHISM INFLUENCES THE SERUM-CHOLESTEROL RESPONSE TO DIETARY INTERVENTION
MANTTARI, M
KOSKINEN, P
EHNHOLM, C
HUTTUNEN, JK
MANNINEN, V
[J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 1991, 40 (02): : 217 - 221
[53] MARTIN LJ, 1993, J LIPID RES, V34, P437
[54] THE APOLIPOPROTEIN EPSILON-4 ALLELE IN PATIENTS WITH ALZHEIMERS-DISEASE
MAYEUX, R
STERN, Y
OTTMAN, R
TATEMICHI, TK
TANG, MX
MAESTRE, G
NGAI, C
TYCKO, B
GINSBERG, H
[J]. ANNALS OF NEUROLOGY, 1993, 34 (05) : 752 - 754
[55] MCLEAN JW, 1984, J BIOL CHEM, V259, P6498
[56] APOLIPOPROTEIN-E POLYMORPHISM AND CORONARY-ARTERY DISEASE
MENZEL, HJ
KLADETZKY, RG
ASSMANN, G
[J]. ARTERIOSCLEROSIS, 1983, 3 (04): : 310 - 315
[57] MIETTINEN TA, 1988, LANCET, V2, P1261, DOI 10.1016/S0140-6736(88)90862-8
[58] APOLIPOPROTEIN-E IMMUNOREACTIVITY IN CEREBRAL AMYLOID DEPOSITS AND NEUROFIBRILLARY TANGLES IN ALZHEIMERS-DISEASE AND KURU PLAQUE AMYLOID IN CREUTZFELDT-JAKOB DISEASE
NAMBA, Y
TOMONAGA, M
KAWASAKI, H
OTOMO, E
IKEDA, K
[J]. BRAIN RESEARCH, 1991, 541 (01) : 163 - 166
[59] APOLIPOPROTEIN-E POLYMORPHISM AND PLASMA-CHOLESTEROL RESPONSE TO PROBUCOL
NESTRUCK, AC
BOUTHILLIER, D
SING, CF
DAVIGNON, J
[J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 1987, 36 (08): : 743 - 747
[60] LIPOPROTEINS AND THEIR GENETIC-VARIATION IN SUBJECTS WITH AND WITHOUT ANGIOGRAPHICALLY VERIFIED CORONARY-ARTERY DISEASE
NIEMINEN, MS
MATTILA, KJ
AALTOSETALA, K
KUUSI, T
KONTULA, K
KAUPPINENMAKELIN, R
EHNHOLM, C
JAUHIAINEN, M
VALLE, M
TASKINEN, MR
[J]. ARTERIOSCLEROSIS AND THROMBOSIS, 1992, 12 (01): : 58 - 69

← 1 2 3 4 5 6 7 8 9 10 →